Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

BMJ criticises new ABPI Code of Practice

The Association of the British Pharmaceutical Industry's new Code of Practice for the Pharmaceutical Industry has been criticised in the British Medical Journal for "lacking teeth". The article is available online.

As already report, the new Code does not come into force until January 2006 but it has already been attacked for being "fundamentally weak" by the editor of the Drugs and Therapeutics Bulletin. Professor Andrew Herxheimer of the Cochrane Centre also stated that, "not much has changed".

Action: Despite the weaknesses of the new code Clinicians should be aware of the Code of Practice and also be prepared to make complaints to the Prescription Medicines Code of Practice Authority or the Medicines and Healthcare products Regulatory Agency.

Share 'BMJ criticises new ABPI Code of Practice' on Email Share 'BMJ criticises new ABPI Code of Practice' on Delicious Share 'BMJ criticises new ABPI Code of Practice' on Digg Share 'BMJ criticises new ABPI Code of Practice' on Facebook Share 'BMJ criticises new ABPI Code of Practice' on Google+ Share 'BMJ criticises new ABPI Code of Practice' on reddit Share 'BMJ criticises new ABPI Code of Practice' on StumbleUpon Share 'BMJ criticises new ABPI Code of Practice' on Twitter

atomic-wealth

No Comments to “BMJ criticises new ABPI Code of Practice”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,521 spam comments.

atomic-wealth
fond-illness
summer